Related Experiment Video
Updated: Feb 21, 2026
08:33
Characterizing Histone Post-translational Modification Alterations in Yeast Neurodegenerative Proteinopathy Models
Published on: March 24, 2019
8.0K
Prying into the Prion Hypothesis for Parkinson's Disease
Patrik Brundin1, Ronald Melki2
1Van Andel Research Institute, Center for Neurodegenerative Science, Grand Rapids, Michigan 49503, and Patrik.Brundin@vai.org Ronald.Melki@cnrs.fr.
Summary
Alpha-synuclein aggregates in Parkinson's disease exhibit prion-like behavior, spreading through neuron-to-neuron transmission. Understanding this mechanism is key to developing new Parkinson's disease therapies.
Area of Science:
- Neuroscience
- Pathology
- Molecular Biology
Background:
- Parkinson's disease is characterized by intracellular alpha-synuclein inclusions in neurons.
- The prion-like behavior of alpha-synuclein is proposed as a key factor in Parkinson's disease pathogenesis.
- Neuron-to-neuron transfer of alpha-synuclein is crucial for the spread of Lewy pathology.
Purpose of the Study:
- To review evidence supporting the prion-like nature of alpha-synuclein in Parkinson's disease.
- To explore triggers for alpha-synuclein misfolding and aggregate escape from cellular degradation.
- To discuss the role of different alpha-synuclein strains in synucleinopathies.
Main Methods:
- Analysis of findings from human postmortem brains.
- Examination of data from cultured cells.
- Review of evidence from animal models of Parkinson's disease.
Main Results:
- Evidence suggests alpha-synuclein can act as a prion.
- Potential triggers for misfolding and resistance to degradation are considered.
- The possibility of distinct alpha-synuclein strains influencing disease presentation is discussed.
Conclusions:
- Alpha-synuclein likely functions as a prion in human diseases.
- Understanding alpha-synuclein's prion-like spread is vital for developing disease-modifying therapies for Parkinson's disease.
More Related Videos
Related Concept Videos
01:15Parkinson's Disease: Overview
2.2K
Neurodegenerative disorders are progressive diseases that cause irreversible damage and loss to neurons in specific brain areas. Examples of these disorders include Parkinson's disease, Alzheimer's disease, Multiple Sclerosis (MS), and Amyotrophic Lateral Sclerosis (ALS). These disorders share characteristics such as proteinopathies, selective neuronal vulnerability, and a complex interplay between genetic and environmental factors. The primary therapeutic goal for these conditions is...
2.2K
03:03Amyloid Fibrils
12.1K
Amyloid fibrils are aggregates of misfolded proteins. Under most circumstances, misfolded proteins are either refolded by chaperone proteins or degraded by the proteasome. However, in the case of a mutation or a disease, these proteins can accumulate to form large clusters and often further assemble to form elongated fibers, called fibrils.
Amyloid deposits were observed as early as 1639 in the liver and the spleen. In 1854, Rudolph Virchow performed iodine staining,...
Amyloid deposits were observed as early as 1639 in the liver and the spleen. In 1854, Rudolph Virchow performed iodine staining,...
12.1K
01:37Neural Regulation
43.6K
Digestion begins with a cephalic phase that prepares the digestive system to receive food. When our brain processes visual or olfactory information about food, it triggers impulses in the cranial nerves innervating the salivary glands and stomach to prepare for food.
43.6K
01:24Parkinson's Disease: Treatment
1.2K
Neurodegenerative disorders, such as Parkinson's Disease (PD), involve the gradual and irreversible destruction of neurons in particular brain areas. These disorders exhibit standard features like proteinopathies, selective vulnerability of some neurons, and an interaction of intrinsic properties, genetics, and environmental influences in neural injury.
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of...
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of...
1.2K
01:22Lysosomal Hydrolases
4.7K
Lysosomes are the site for the degradation of macromolecules and biological polymers released during membrane trafficking events such as secretory, endocytic, autophagic, and phagocytic pathways. The membrane-enclosed area of the lysosome, called the lumen, contains hydrolytic enzymes active in an acidic environment. These acid hydrolases are functional at a pH between 4.5 and 5 and are involved in cellular processes such as cell signaling, energy metabolism, restoration of the plasma membrane,...
4.7K
01:27Psychosis: Pathophysiology of Schizophrenia and Other Psychotic Disorders
2.2K
Schizophrenia is a neurodevelopmental disorder whose origins are rooted in complex genetic components. Despite our burgeoning understanding, the pathophysiology of this disorder remains incompletely deciphered.
Researchers have identified genetic factors that increase susceptibility to schizophrenia, underscoring the intricate interplay between genetics and environment in disease development. At the core of schizophrenia's pathophysiology is excessive dopaminergic neurotransmission within...
Researchers have identified genetic factors that increase susceptibility to schizophrenia, underscoring the intricate interplay between genetics and environment in disease development. At the core of schizophrenia's pathophysiology is excessive dopaminergic neurotransmission within...
2.2K